Adults, Cholecystectomy, Cholecystitis, Gallbladder Dyskinesia, Gall Stone, Pancreatitis Biliary, Polyps
Conditions
Keywords
Algeria, Cholecystectomy, mortality, morbidity, 30 days, determinants
Brief summary
Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices. In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.
Detailed description
This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria. This information is crucial for benchmarking existing practices, pinpointing areas for enhancement, and ultimately improving patient safety and surgical effectiveness.
Interventions
None listed
Sponsors
University of Oran 1
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged 18 years and older. * Undergoing cholecystectomy. * Surgery performed in public or private hospitals in Algeria. * Surgery performed from January 1, 2025, to June 30, 2025.
Exclusion criteria
* Patients younger than 18 years. * Patients refusing to participate. * Cholecystectomy performed for Gallbladder cancer. * Cholecystectomy performed outside the inclusion period. * Cholecystectomies performed in conjunction with other major surgeries.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| factors associated with 30-day morbidity and mortality | occuring in of before 30 day postopérative période. | determinants of the occurence of complications and mortality on or before 30 day in postopérative period |
| Evaluate the 30-day mortality and morbidity | occuring in of before 30 day postopérative période. | Evaluation of rate of mortality and morbidity at 30 day |
Secondary
| Measure | Time frame |
|---|---|
| estimate the incidence of incidental gallbladder cancer discovered during cholecystectomy in Algeria. | postoperative periode ( during or after surgical procedure) |
| estimate the incidence of bile duct injuries following cholecystectomy for benign diseases | occuring in of before 30 day postopérative periode. |
| assess surgical practices related to cholecystectomy in Algeria. | During surgical procedure ( Cholecystectomy) |
Contacts
Primary ContactAnisse Tidjane, Pr
Outcome results
None listed